Postextraction Mucormycosis in Immunocompromised-Patient Management and Review of Literature.


Journal

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
ISSN: 1531-5053
Titre abrégé: J Oral Maxillofac Surg
Pays: United States
ID NLM: 8206428

Informations de publication

Date de publication:
07 2021
Historique:
received: 07 10 2020
revised: 16 01 2021
accepted: 16 01 2021
pubmed: 23 2 2021
medline: 4 8 2021
entrez: 22 2 2021
Statut: ppublish

Résumé

Mucormycosis is an uncommon aggressive, opportunistic infection that can produce widespread orofacial tissue necrosis. This primarily affects immunocompromised individuals. It is the deadliest and most rapidly progressing type of human-affecting fungal infection. The aim of the study is to investigate the diagnostic criteria and treatment approach in 10 cases of mucormycosis in the author's institute from 2008 to 2019. Moreover, a review of the English literature presents all cases of mucormycosis after tooth extraction. Ten patients at our institute have been treated. They were evaluated and discussed as per their diagnostic criteria, surgical treatment, and mortality rates. All 10 immunocompromised patients had a primary hematologic malignancy. The criteria for a positive diagnosis were clinical symptoms and a biopsy for microbiological culture and histologic analysis. Each patient was subjected to vigorous surgical resection and underwent antifungal treatment. Seven patients died because of their main disease. Owing to the unregulated spread of mucormycosis, 2 patients died. Four cases were diagnosed after maxillary tooth extraction. The most important factor for patient survival tends to be the management of the underlying disease with early detection and active surgical and antifungal action. Four of 10 cases diagnosed with mucormycosis appeared after tooth extraction, a relatively high number compared with the literature. Therefore, it is the dental profession's obligation to be familiar with the possibility of the potentially severe and possibly fatal complication.

Identifiants

pubmed: 33617788
pii: S0278-2391(21)00085-9
doi: 10.1016/j.joms.2021.01.019
pii:
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1482-1491

Informations de copyright

Copyright © 2021 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Omri Emodi (O)

Deputy Head, Department of Oral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel; and Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Chaim Ohayon (C)

Resident, Department of Oral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel. Electronic address: Haim.ohayon@mail.huji.ac.il.

Amir Bilder (A)

Master Student, Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Tal Capucha (T)

Resident, Department of Oral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel.

Amir Wolff (A)

Senior, Department of Oral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel; and Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Adi Rachmiel (A)

Department Head, Department of Oral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel, and Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH